These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 26988602)

  • 1. EGFR targeted nanobody-photosensitizer conjugates for photodynamic therapy in a pre-clinical model of head and neck cancer.
    van Driel PBAA; Boonstra MC; Slooter MD; Heukers R; Stammes MA; Snoeks TJA; de Bruijn HS; van Diest PJ; Vahrmeijer AL; van Bergen En Henegouwen PMP; van de Velde CJH; Löwik CWGM; Robinson DJ; Oliveira S
    J Control Release; 2016 May; 229():93-105. PubMed ID: 26988602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanobody-targeted photodynamic therapy induces significant tumor regression of trastuzumab-resistant HER2-positive breast cancer, after a single treatment session.
    Deken MM; Kijanka MM; Beltrán Hernández I; Slooter MD; de Bruijn HS; van Diest PJ; van Bergen En Henegouwen PMP; Lowik CWGM; Robinson DJ; Vahrmeijer AL; Oliveira S
    J Control Release; 2020 Jul; 323():269-281. PubMed ID: 32330574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanobody-photosensitizer conjugates for targeted photodynamic therapy.
    Heukers R; van Bergen en Henegouwen PM; Oliveira S
    Nanomedicine; 2014 Oct; 10(7):1441-51. PubMed ID: 24394212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute cellular and vascular responses to photodynamic therapy using EGFR-targeted nanobody-photosensitizer conjugates studied with intravital optical imaging and magnetic resonance imaging.
    de Bruijn HS; Mashayekhi V; Schreurs TJL; van Driel PBAA; Strijkers GJ; van Diest PJ; Lowik CWGM; Seynhaeve ALB; Hagen TLMT; Prompers JJ; Henegouwen PMPVBE; Robinson DJ; Oliveira S
    Theranostics; 2020; 10(5):2436-2452. PubMed ID: 32089747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanobody-Targeted Photodynamic Therapy Selectively Kills Viral GPCR-Expressing Glioblastoma Cells.
    De Groof TWM; Mashayekhi V; Fan TS; Bergkamp ND; Sastre Toraño J; van Senten JR; Heukers R; Smit MJ; Oliveira S
    Mol Pharm; 2019 Jul; 16(7):3145-3156. PubMed ID: 31244224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A cell-targeted photodynamic nanomedicine strategy for head and neck cancers.
    Master A; Malamas A; Solanki R; Clausen DM; Eiseman JL; Sen Gupta A
    Mol Pharm; 2013 May; 10(5):1988-97. PubMed ID: 23531079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of subcellular localization on the efficiency of EGFR-targeted VHH photosensitizer conjugates.
    van Lith SAM; van den Brand D; Wallbrecher R; Wübbeke L; van Duijnhoven SMJ; Mäkinen PI; Hoogstad-van Evert JS; Massuger L; Ylä-Herttuala S; Brock R; Leenders WPJ
    Eur J Pharm Biopharm; 2018 Mar; 124():63-72. PubMed ID: 29274374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EGFR-Targeted Nanobody Functionalized Polymeric Micelles Loaded with mTHPC for Selective Photodynamic Therapy.
    Liu Y; Scrivano L; Peterson JD; Fens MHAM; Hernández IB; Mesquita B; Toraño JS; Hennink WE; van Nostrum CF; Oliveira S
    Mol Pharm; 2020 Apr; 17(4):1276-1292. PubMed ID: 32142290
    [No Abstract]   [Full Text] [Related]  

  • 9. Investigation of the Therapeutic Potential of Nanobody-Targeted Photodynamic Therapy in an Orthotopic Head and Neck Cancer Model.
    van Driel PBAA; Keereweer S; Lowik CWGM; Oliveira S
    Methods Mol Biol; 2022; 2451():521-531. PubMed ID: 35505029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Orthotopic Breast Cancer Model to Investigate the Therapeutic Efficacy of Nanobody-Targeted Photodynamic Therapy.
    Deken MM; Bhairosingh SS; Vahrmeijer AL; Oliveira S
    Methods Mol Biol; 2022; 2451():547-556. PubMed ID: 35505031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted Photodynamic Therapy (PDT) of Lung Cancer with Biotinylated Silicon (IV) Phthalocyanine.
    Dong W; Li K; Wang S; Qiu L; Liu Q; Xie M; Lin J
    Curr Pharm Biotechnol; 2021; 22(3):414-422. PubMed ID: 32386488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In Vitro Assessment of Binding Affinity, Selectivity, Uptake, Intracellular Degradation, and Toxicity of Nanobody-Photosensitizer Conjugates.
    Beltrán Hernández I; De Groof TWM; Heukers R; Oliveira S
    Methods Mol Biol; 2022; 2451():505-520. PubMed ID: 35505028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metoclopramide enhances the effect of photodynamic therapy on xenografted human squamous cell carcinoma of the head and neck.
    Werning JW; Stepnick DW; Jafri A; Megerian CA; Antunez AR; Zaidi SI
    Arch Otolaryngol Head Neck Surg; 1995 Jul; 121(7):783-9. PubMed ID: 7598858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. VHH-Photosensitizer Conjugates for Targeted Photodynamic Therapy of Met-Overexpressing Tumor Cells.
    Heukers R; Mashayekhi V; Ramirez-Escudero M; de Haard H; Verrips TC; van Bergen En Henegouwen PMP; Oliveira S
    Antibodies (Basel); 2019 Apr; 8(2):. PubMed ID: 31544832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimization of a nanomedicine-based silicon phthalocyanine 4 photodynamic therapy (Pc 4-PDT) strategy for targeted treatment of EGFR-overexpressing cancers.
    Master AM; Livingston M; Oleinick NL; Sen Gupta A
    Mol Pharm; 2012 Aug; 9(8):2331-8. PubMed ID: 22775587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual Targeting of Endothelial and Cancer Cells Potentiates In Vitro Nanobody-Targeted Photodynamic Therapy.
    Mashayekhi V; Xenaki KT; van Bergen En Henegouwen PMP; Oliveira S
    Cancers (Basel); 2020 Sep; 12(10):. PubMed ID: 32977602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Photodynamic therapy of human squamous cell carcinoma in vitro and in xenografts in nude mice.
    Megerian CA; Zaidi SI; Sprecher RC; Setrakian S; Stepnick DW; Oleinick NL; Mukhtar H
    Laryngoscope; 1993 Sep; 103(9):967-75. PubMed ID: 8361317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vandetanib sensitizes head and neck squamous cell carcinoma to photodynamic therapy through modulation of EGFR-dependent DNA repair and the tumour microenvironment.
    Chu PL; Shihabuddeen WA; Low KP; Poon DJJ; Ramaswamy B; Liang ZG; Nei WL; Chua KLM; Thong PSP; Soo KC; Yeo ELL; Chua MLK
    Photodiagnosis Photodyn Ther; 2019 Sep; 27():367-374. PubMed ID: 31299389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant human tumor necrosis factor alpha does not potentiate cell killing after photodynamic therapy with a silicon phthalocyanine in A431 human epidermoid carcinoma cells.
    Azizuddin K; Kalka K; Chiu SM; Ahmad N; Mukhtar H; Separovic D
    Int J Oncol; 2001 Feb; 18(2):411-5. PubMed ID: 11172611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted Photodynamic Therapy of Human Head and Neck Squamous Cell Carcinoma with Anti-epidermal Growth Factor Receptor Antibody Cetuximab and Photosensitizer IR700DX in the Mouse Skin-fold Window Chamber Model.
    Peng W; de Bruijn HS; Ten Hagen TLM; van Dam GM; Roodenburg JLN; Berg K; Witjes MJH; Robinson DJ
    Photochem Photobiol; 2020 May; 96(3):708-717. PubMed ID: 32222965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.